#Veeva Systems #AstraZeneca #AI Innovations #Denmark #Copenhagen

Innovations in AI and Data from Veeva Summit

A significant event in the life sciences sector is on the horizon as Veeva Systems announces the upcoming Veeva Commercial Summit Europe. Scheduled for November 18-19 in Copenhagen, Denmark, this summit promises to be a melting pot of innovative strategies aimed at transforming agent-centric business models.

The summit will feature prominent speakers from leading pharmaceutical companies, including AstraZeneca, Bristol Myers Squibb, Grünenthal, Novo, Roche, and UCB. These industry leaders will share their valuable insights on how to drive commercial and medical excellence utilizing the latest advancements in artificial intelligence (AI) and data analytics.

As the pharmaceutical landscape evolves, harnessing AI tailored to the unique requirements of the sector is crucial. Attendees will have the opportunity to learn how sales and marketing teams can enhance customer interactions, gain insightful data, and accelerate content delivery while ensuring compliance with regulatory standards. This integration of digital and face-to-face engagements aims to produce actionable commercial evidence, providing biopharmaceutical companies with a deeper understanding of healthcare professionals' and patients' needs. Moreover, it seeks to enhance treatment outcomes effectively.

The Veeva Commercial Summit is recognized as one of the largest gatherings of life sciences professionals in Europe, attracting over 1,200 industry experts. With more than 100 sessions focused on client success stories and AI innovations via Veeva's Commercial Cloud and Data Cloud, this summit promises a wealth of knowledge and networking opportunities. Key themes include:

• - Unlocking new capabilities with an agent-based commercial model
• - Maximizing customer engagement through integrated service experiences in person and online
• - Offering healthcare professionals an intelligent and personalized journey with advanced customer relationship management (CRM) tools
• - Utilizing conversational AI to identify and address treatment barriers on brand websites
• - Streamlining promotional content approval processes and boosting productivity through agent-led MLR (Medical, Legal, and Regulatory) strategies
• - Leveraging data on healthcare professional access to improve sales strategies and field guidance
• - Creating reliable global databases to expand the use of AI, facilitating better decision-making across markets
• - Transforming medical insights into actionable strategies to improve patient outcomes

Chris Moore, President of Veeva Europe, emphasized, "The pace of innovation in the life sciences sector is accelerating, and AI is opening up new avenues for more meaningful and timely interactions with healthcare professionals and patients." He further stated, "The Veeva Summit gathers a community of leaders to exchange knowledge and ideas as the industry moves toward an agent commercial model."

Exclusively open to life sciences professionals, attendees can register for this impactful summit at veeva.com/eu/Summit. With Veeva Systems committed to providing the industry's cloud solution with software, data, and consulting services, the event is not to be missed for those focused on innovation and excellence in the life sciences field.

In conclusion, as major players like AstraZeneca and Bristol Myers Squibb showcase their AI-driven initiatives, the Veeva Commercial Summit highlights the transformative impact of technology in enhancing business strategies and ultimately, improving patient care within the pharmaceutical landscape.